SCHEMBL19566535

SCHEMBL19566535

B[C@@H]1O[C@H](COC)[C@H](OP(=O)(S)CC)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17754490 1.00 — —
SCHEMBL17754512 1.00 — —
SCHEMBL17754508 0.87 — —
SCHEMBL17754500 0.86 SMPD1 (0.34) —
SCHEMBL17754493 0.86 — —
SCHEMBL17754513 0.86 — —
SCHEMBL17754502 0.83 — —
SCHEMBL17754494 0.79 — —
SCHEMBL17754495 0.79 — —
SCHEMBL17251315 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170319614-A1 ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING Neurovision Pharma GmbH (DE) 2017-11-09 — — US disclosed
Send feedback